Blog

Pathogen Detection

Pathogen Detection

In a world where timely identification of pathogens is essential to preventing outbreaks, protecting crops, and managing global health crises, pathogen detection technology has become more important than ever. Traditional culture-based methods often fall short in sensitivity and speed, whereas modern molecular tools—particularly PCR pathogen detection—offer a faster, more accurate alternative.

At 3CR Bioscience, we’ve taken PCR-based detection to the next level with our patented PACE® and PACE OneStep RT-PCR technologies. Designed for flexibility and high throughput, our systems are used globally across sectors including agriculture, clinical research, and environmental monitoring. This article explores the benefits of PCR-based pathogen detection systems, with real-world case studies demonstrating the power and versatility of our approach.

Why PCR-Based Pathogen Detection?

Polymerase chain reaction (PCR) enables the amplification of target DNA or RNA sequences with unmatched sensitivity and specificity. In pathogen detection systems, PCR can identify pathogens at the earliest stages of infection—before symptoms appear or contaminants spread.

Compared to traditional methods like microbial culture or immunoassays, rapid pathogen detection using PCR drastically reduces time to result, improves diagnostic accuracy, and supports earlier intervention or containment strategies.

PACE and PACE OneStep RT-PCR: Sensitivity and Precision in High-Throughput PCR Pathogen Detection

At the core of 3CR’s technology is PACE (PCR Allele Competitive Extension)—a patented, high-performance fluorescent PCR genotyping chemistry. PACE enables accurate detection of DNA variants, including single nucleotide polymorphisms (SNPs), across diverse organisms.

Our enhanced PACE OneStep RT-PCR integrates reverse transcription and PCR into a single reaction, allowing for the detection of both DNA- and RNA-based pathogens. This innovation supports rapid pathogen detection workflows that are high-throughput, cost-effective, and easy to adopt.

How PACE Works in Pathogen Detection

PACE assays are tailored to target unique genetic sequences found in pathogen genomes, enabling specific and reliable detection. They can be designed to:

  • Identify the presence or absence of a pathogen in a sample.
  • Distinguish between strains or variants of the same pathogen.
  • Track the evolution of pathogens over time or across populations.

Advantages of Using PACE-Based Systems

Speed: Results in hours, not days.

High Throughput: Ideal for screening hundreds or thousands of samples.

Cost Efficiency: Uses universal reagents with minimal primer requirements.

Flexibility: Detects pathogens in plants, animals, humans, or environmental samples.

Scalability: Easily adapted to different lab workflows or sample volumes.

Case Study: SARS-CoV-2 Variant Detection in Human Populations

During the COVID-19 pandemic, genetic surveillance of viral variants became a global priority. Traditional whole-genome sequencing, though powerful, was expensive and logistically challenging for widespread use.

In response, 3CR Bioscience partnered with the University of Bristol to develop a PACE OneStep RT-PCR pipeline for rapid pathogen detection and variant tracking of SARS-CoV-2. Instead of sequencing entire genomes, the method genotyped SNPs directly from RNA samples to differentiate circulating viral strains.

A workflow showing how SARS-CoV-2 PCR genotyping can be used to identify circulating SARS-CoV-2 variants for pathogen detection and monitoring.

High-Resolution Tracking with Minimal Resources

Using a panel of just 19 SNP markers, the team could distinguish 59 different SARS-CoV-2 genotypes. This rapid, low-cost method provided critical insights into transmission patterns and the emergence of variants, without overburdening testing infrastructure.

The publicly available SNP genotyping pipeline has since been adopted by public health labs for real-time variant monitoring and remains adaptable as new variants arise.

Case Study: Pathogen Detection in Cotton Crops

In agriculture, early pathogen detection is vital to preventing the spread of crop diseases. One such threat is Cotton leafroll dwarf virus (CLRDV)—a single-stranded RNA virus that can cause devastating yield losses.

From Two-Step to One-Step Detection

Researchers at Texas A&M University collaborated with 3CR Bioscience to streamline detection of CLRDV. Building on the lab’s existing use of PACE genotyping, they developed a PACE OneStep RT-PCR assay that combined reverse transcription and DNA amplification into a single step.

The assay accurately differentiated infected and healthy plants and was validated against known sample sets. Its low cost, speed, and simplicity make it ideal for widescale crop monitoring.

A workflow and data plot showing how PACE PCR genotyping can be used for pathogen detection, to detect Cotton Leafroll Dwarf Virus in Cotton crops.

Customisable for Other Crop Threats

Thanks to its modular design, PACE and PACE OneStep RT-PCR can be adapted to target other plant pathogens by altering the primer sequences. This makes it a valuable platform for responding to emerging threats in global agriculture.

Pathogen Detection and Beyond

Beyond direct pathogen detection, PACE technology supports broader research in genomics and epidemiology. Its ability to detect SNPs and small insertions/deletions (Indels) enables investigations into:

  • Genetic predispositions to human diseases such as cancer and cardiovascular conditions.
  • Outbreak investigations involving bacterial, viral, or fungal pathogens.
  • Environmental pathogen monitoring in water or soil samples.
  • PACE offers a reliable tool for both clinical research and public health surveillance.

An Open Invitation for Collaboration and Feedback

At 3CR Bioscience, we’re proud to support researchers and organisations working on the front lines of health, agriculture, and environmental safety. We’re continually refining our pathogen detection systems and welcome feedback from our users on how we can improve our solutions or support emerging needs.

Whether you’re working in diagnostics, research, or regulatory monitoring, we invite you to explore how PACE or PACE OneStep RT-PCR can be adapted for your application. From customised assay development to high-throughput implementation, our team is here to help.

Conclusion

The need for rapid pathogen detection continues to grow across industries. Whether monitoring disease in humans, plants, or animals, fast and accurate monitoring are essential to mitigating risk, protecting supply chains, and saving lives.

3CR Bioscience’s PCR-based solutions, including PACE and PACE OneStep RT-PCR, provide a scalable, versatile, and cost-effective approach to pathogen detection. Backed by real-world success stories and an ongoing commitment to innovation, our technology is redefining the frontiers of molecular diagnostics.

If you’re looking to implement or improve your pathogen detection system, contact us to learn how PACE can work for you.

MORE POSTS

Pathogen Detection
PACE for rapid, sensitive pathogen detection - customised precision technology for the fast, one-step detection of DNA and RNA-based pathogens. Proven efficacy and sensitivity across agricultural, veterinary, and medical applications.
What is a PCR Master Mix?
A general introduction to PCR master mixes followed by information on 3CR Bioscience’s PACE PCR Master Mixes, which provide cost-effective solutions for accurate SNP and Indel genotyping, using patented fluorescent technology for high-throughput, reliable allele-specific PCR analysis.
PCR Instrumentation: Transforming Genotyping with Automation
PCR instrumentation has evolved from manual setups to automated systems, enhancing efficiency, accuracy, and scalability in genotyping. 3CR Bioscience offers advanced solutions for PCR instrumentation and integration into a wide range of workflows.
[fibosearch]
Name(Required)
This field is for validation purposes and should be left unchanged.

Contact us

MEET OUR TEAM

Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASPâ„¢, KlearKall, KlearGene, KlearAmp and KlearTaqâ„¢, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.